Market Highlights: Amylyx Pharmaceuticals Inc (AMLX) Ends on a High Note at 1.72

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed at $1.72 in the last session, up 2.38% from day before closing price of $1.68. In other words, the price has increased by $2.38 from its previous closing price. On the day, 2.05 million shares were traded. AMLX stock price reached its highest trading level at $1.725 during the session, while it also had its lowest trading level at $1.6512.

Ratios:

We take a closer look at AMLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.58. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on March 18, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $32 previously.

On March 11, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $37 to $4.

Leerink Partners Downgraded its Outperform to Market Perform on March 11, 2024, whereas the target price for the stock was revised from $27 to $4.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’24 when Quimi Daphne bought 2,250 shares for $1.89 per share. The transaction valued at 4,252 led to the insider holds 5,000 shares of the business.

Mazzariello Gina sold 10,455 shares of AMLX for $19,654 on May 15 ’24. The Chief Legal Officer now owns 151,477 shares after completing the transaction at $1.88 per share. On May 14 ’24, another insider, Quimi Daphne, who serves as the Director of the company, bought 2,750 shares for $1.89 each. As a result, the insider paid 5,184 and bolstered with 2,750 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 116969976 and an Enterprise Value of -252629104. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at -0.635 whereas that against EBITDA is 3.155.

Stock Price History:

Over the past 52 weeks, AMLX has reached a high of $26.44, while it has fallen to a 52-week low of $1.65. The 50-Day Moving Average of the stock is -19.51%, while the 200-Day Moving Average is calculated to be -86.34%.

Shares Statistics:

According to the various share statistics, AMLX traded on average about 3.37M shares per day over the past 3-months and 1208860 shares per day over the past 10 days. A total of 67.71M shares are outstanding, with a floating share count of 45.89M. Insiders hold about 32.52% of the company’s shares, while institutions hold 71.21% stake in the company. Shares short for AMLX as of 1715731200 were 7989883 with a Short Ratio of 2.37, compared to 1713139200 on 6512835. Therefore, it implies a Short% of Shares Outstanding of 7989883 and a Short% of Float of 12.93.

Most Popular